Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Watson Pharmaceuticals

This article was originally published in The Tan Sheet

Executive Summary

New York City appeals court will consider on Jan. 13 SmithKline Beecham's request that the preliminary injunction barring distribution of Watson's private label nicotine polacrilex gum not be lifted. A Manhattan district court modified the injunction Dec. 22 allowing Watson to ship the gum with a revised user's guide and audiocassette; the revised versions were approved by FDA Dec. 27. SB (maker of Nicorette) appealed the court's decision and a stay has been granted until the appeals court ruling. SmithKline originally filed suit Aug. 26, alleging copyright infringement due to Watson's identical user's guide and audiocassette (1"The Tan Sheet" Sept. 6, 1999, p. 3)
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS090754

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel